WuXi NextCODE rebrands as Genuity Science, sheds Shanghai operations
Genomics informatics and sequencing service giant WuXi NextCODE is rebranding itself as Genuity Science. But the new firm will be running without its Shanghai operations, even though it’s considered a sister firm to Chinese CRO WuXi AppTec. The decision to separate its China business comes as pressure mounts from both sides of the Pacific over genomics data security. Last June, China passed the Human Genetic Resource Regulation that restricts export of Chinese human genetic information.
2026-10-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
Recommend Reading
-
Hormuz in Crisis: Freight Rates Surge to $6,000 as Global Trade Feels the Shock
-
Indorama Corporation Acquires 100% Stake in Anyang Zhongying Fertilizer
-
“Anti-Overcapacity” Backfires: China’s Chemical Industry Trapped in a Hell of Its Own Making—and Global Pushback
-
Saint-Gobain Expands Its Construction Chemicals Operations in Indonesia
-
Domo Chemicals’ German Subsidiary Insolvencies: Energy Costs, Weak Demand and Chinese Nylon Competition
-
This Week's Activated Carbon Prices Rise in China (1.5-1.9)
-
Geopolitical Risks Escalate, Acrylonitrile Prices Rise Driven by Cost Increases in China
-
This week, the Aniline market in China showed a strong increase (1.5-1.9)
-
Cost-driven fluctuations and decline in phthalic anhydride market prices in 2025; prices may first strengthen and then stabilize in 2026
-
This Week's Styrene Market Slightly Rises (1.5-1.9) in China